SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 77 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $103 | -16.3% | 12,107 | +0.3% | 0.00% | – |
| Q1 2024 | $123 | +86.4% | 12,076 | -0.3% | 0.00% | – |
| Q4 2023 | $66 | +43.5% | 12,112 | -0.3% | 0.00% | – |
| Q3 2023 | $46 | -56.2% | 12,153 | -22.1% | 0.00% | – |
| Q2 2023 | $105 | -89.5% | 15,600 | +9130.8% | 0.00% | – |
| Q2 2022 | $1,000 | -97.5% | 169 | -98.5% | 0.00% | – |
| Q1 2022 | $40,000 | -47.4% | 11,469 | 0.0% | 0.00% | – |
| Q4 2021 | $76,000 | -33.3% | 11,469 | 0.0% | 0.00% | – |
| Q3 2021 | $114,000 | -67.6% | 11,469 | +0.5% | 0.00% | – |
| Q2 2021 | $352,000 | +4.8% | 11,409 | +48.2% | 0.00% | – |
| Q1 2021 | $336,000 | – | 7,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,740,887 | $87,234,000 | 0.96% |
| Boxer Capital, LLC | 1,675,377 | $16,720,000 | 0.58% |
| EcoR1 Capital, LLC | 1,184,710 | $11,823,000 | 0.41% |
| Nantahala Capital Management | 1,226,631 | $12,242,000 | 0.39% |
| 5AM Venture Management, LLC | 169,748 | $1,694,000 | 0.34% |
| COMMODORE CAPITAL LP | 97,143 | $969,000 | 0.26% |
| RA Capital Management | 1,742,186 | $17,387,000 | 0.24% |
| HighVista Strategies LLC | 22,434 | $224,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 150,000 | $1,497,000 | 0.10% |
| Woodline Partners LP | 425,261 | $4,244,000 | 0.07% |